Balance Sheet - ARS Pharmaceuticals, Inc. (SPRY)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | |
|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 0.24 | 0.31 | 0.23 | 0.27 | 0.06 | 0.02 | 0.01 | 0.02 |
| Accounts receivable, net | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Inventories | 0.01 | 0.01 | 0.00 | 0.00 | -0.01 | 0.00 | ||
| Other current assets | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total current assets | 0.28 | 0.33 | 0.23 | 0.28 | 0.06 | 0.03 | 0.01 | 0.02 |
| Total non-current assets | 0.04 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Total assets | 0.33 | 0.35 | 0.23 | 0.28 | 0.06 | 0.03 | 0.02 | 0.03 |
| Total current liabilities | 0.04 | 0.02 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
| Total non-current liabilities | 0.17 | 0.07 | 0.00 | 0.00 | 0.08 | 0.03 | 0.00 | 0.00 |
| Total liabilities | 0.21 | 0.09 | 0.00 | 0.01 | 0.09 | 0.04 | 0.02 | 0.01 |
| Total stockholders' equity | 0.11 | 0.26 | 0.23 | 0.27 | -0.03 | -0.01 | -0.01 | 0.02 |
| Common shares outstanding | 99 | 102 | 95 | 40 | 29 | 35 | 33 | 33 |
Show Quarterly Balance Sheet
Balance Sheet - ARS Pharmaceuticals, Inc. (SPRY)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Jun-20 | Mar-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 0.20 | 0.24 | 0.29 | 0.24 | 0.28 | 0.31 | 0.20 | 0.22 | 0.22 | 0.23 | 0.24 | 0.25 | 0.26 | 0.27 | 0.10 | 0.08 | 0.25 | 0.06 | 0.30 | 0.36 | 0.37 | 0.39 | 0.00 | 0.00 | 0.01 |
| Accounts receivable, net | 0.03 | 0.03 | 0.04 | 0.03 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Inventories | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Other current assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Total current assets | 0.25 | 0.28 | 0.34 | 0.28 | 0.30 | 0.33 | 0.21 | 0.22 | 0.23 | 0.23 | 0.24 | 0.26 | 0.27 | 0.28 | 0.04 | 0.05 | 0.26 | 0.06 | 0.31 | 0.36 | 0.38 | 0.39 | 0.01 | ||
| Total non-current assets | 0.04 | 0.04 | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 | 0.01 | ||
| Total assets | 0.29 | 0.33 | 0.37 | 0.31 | 0.33 | 0.35 | 0.22 | 0.22 | 0.23 | 0.23 | 0.25 | 0.26 | 0.27 | 0.28 | 0.04 | 0.05 | 0.31 | 0.06 | 0.35 | 0.37 | 0.38 | 0.39 | 0.02 | ||
| Total current liabilities | 0.05 | 0.04 | 0.05 | 0.05 | 0.03 | 0.02 | 0.02 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | ||
| Total non-current liabilities | 0.18 | 0.17 | 0.17 | 0.08 | 0.07 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.08 | 0.00 | 0.08 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Total liabilities | 0.23 | 0.21 | 0.23 | 0.12 | 0.10 | 0.09 | 0.02 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.09 | 0.02 | 0.09 | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | ||
| Total stockholders' equity | 0.06 | 0.11 | 0.15 | 0.19 | 0.23 | 0.26 | 0.20 | 0.22 | 0.22 | 0.23 | 0.24 | 0.25 | 0.26 | 0.27 | 0.03 | -0.04 | 0.29 | -0.03 | 0.33 | 0.35 | 0.37 | 0.38 | -0.01 | ||
| Common shares outstanding | 99 | 99 | 99 | 98 | 98 | 98 | 97 | 97 | 96 | 96 | 96 | 95 | 94 | 94 | 94 | 94 | 94 | 35 | 35 | 35 | 35 | 35 | 35 | 33 | 33 |